Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
about
Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingToll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in ratsNADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytesTranscriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patientsToll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisAdipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance.CD47 and TLR-2 cross-talk regulates neutrophil transmigration.Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acidSuppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27Intracellular signal pathways: potential for therapies.Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells.Nucleic acid-binding polymers as anti-inflammatory agentsArthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblastsBlockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant culturesInterplay between innate and adaptive immunity in the development of non-infectious uveitisDoes helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritisCD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting.The role of Src kinase in macrophage-mediated inflammatory responses.The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalisActivation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.Analysing the role of endogenous matrix molecules in the development of osteoarthritis.Innate immune signals in autoimmune and autoinflammatory uveitis.TLRs, future potential therapeutic targets for RA.Molecular cloning and characterization of a novel anti-TLR9 intrabody.The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands.Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor.The potential importance of Toll-like receptors in ankylosing spondylitis.Transcriptional profiling of liver and effect of glucocorticoids in a rat adjuvant-induced arthritis model.Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene.Current and emerging therapeutic strategies for Fanconi anemia.Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior.[EXPRESS] TLR4/NF-κB signaling activation in plantar tissue and dorsal root ganglion involves in the development of postoperative painOverexpression of Toll-Like Receptor 3 in Spleen is Associated with Experimental Arthritis in Rats
P2860
Q27661754-89EBAF23-A47E-4073-AD31-4B5C54CE25B8Q28567867-F989E602-3338-4BFB-B2F9-B15B6E0186E7Q28571580-EC5B8108-74AC-48CC-88C6-B68A7F79CF89Q33497339-68FDC809-FE0E-458C-BB44-845CE91499FAQ33740199-7A16580C-4EB7-4AB3-8C25-2BB964B6866DQ33793807-2C61D24F-A997-4BCB-BCCF-91C8D7B1079FQ33853953-A434A55C-5831-4184-9409-4097518B28ECQ34380068-781E9268-EB85-4EA2-984C-37625B2AC05DQ34482169-885CD4C0-8565-40D5-B366-61C0E5265E5EQ34551138-BCCBC550-3A77-4B37-B66C-9544C5D0F8FDQ34672043-345F37E4-BC78-44E3-BF3B-17CFD8AE15BBQ35055182-AA6C7394-25D3-4FDB-BAFE-2FBA2B760635Q35180765-07F0F433-55F7-4DB8-8B98-FD2BD7185EABQ35557956-2F5A5609-19AF-470A-BFD5-362F9142EF74Q35620370-B3453C6F-5F88-44D2-BED6-F6C31BF28394Q35784059-E614BB36-838C-4A55-898B-2066E3EFE9C5Q36186594-A580FCDB-E2BF-40D7-8DC9-4A7952AE144FQ36246077-4289152D-462A-4F39-94AA-E35D4D96E64FQ36385906-FA4B4B5D-F9E4-40D7-9ED6-B671CE571C6DQ36418104-9F7B4CE9-0646-4DA1-A929-9A141F0101C9Q36572635-21A8A8EC-33B9-4F89-A4E3-587F7C544E60Q37164554-52FB5D96-3A4E-4D06-AB59-9D7497AB2560Q37283829-48EE6601-10AE-4F07-99EC-232914C83EA4Q37484487-FE16CC49-5653-45F5-B141-CC790ED33E22Q37599914-A7A72CD4-C9B1-4997-9142-4959FCE63409Q38077551-D27B0C8B-3D78-4890-8E1A-07574C282FA9Q38781354-E92F7DBE-BE5D-423C-9C45-A0BE1F8613CDQ39119214-0E16BAB1-A19A-4F06-BC40-AD1C9E43B473Q39723354-DF1A847F-42CD-4AFD-82C6-C186472F9F98Q40137389-63197389-F72A-4081-994A-90A2008B0D9DQ42622426-84DDEA15-6536-451C-97A3-A23BE9A9EF2DQ42780994-903270F5-1113-49E5-BC54-14157D4B7D78Q44519335-31AC9F7F-75DF-49E6-AFC2-AE21ABB3A0A3Q45871170-6246552B-2DC3-41BB-B770-C5FC2288501EQ47810676-04E56528-58FD-4AB5-B359-C30A6B51617CQ57059739-A5674111-705F-44DF-A2B1-66EAF57DD98FQ58809183-C87C3721-D50A-4A41-BFF8-DAAA7AFE103F
P2860
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@en
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@nl
type
label
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@en
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@nl
prefLabel
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@en
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@nl
P356
P1476
Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
@en
P2093
Luke A J O'Neill
P304
P356
10.1038/NCPRHEUM0802
P577
2008-04-29T00:00:00Z